Charles D. Meyers - Concepedia

Author

Charles D. Meyers

Also Known As

C Daniel Meyers, C. D. Meyers, C. Daniel Meyers, C.D. Meyers, C.Daniel Meyers, CHARLES D. MEYERS, Charles D Meyers, Charles D. Meyers, Charles Daniel Meyers, Charles Meyers

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)University of California, Irvine Novartis (United States)University of Washington Boston Biomedical Research Institute

About

Charles D. Meyers is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	288
2	Diabetes	4	4	94
3	Health Sciences	2	2	42
4	Biochemistry	2	2	42
5	Cellular Physiology	1	1	55

Charles D. Meyers

Publications

897

Citations

H-Index

Page 1

	Year	Citations
Niacin therapy in atherosclerosis Charles D. Meyers, Vajinath S Kamanna, Moti L. Kashyap Current Opinion in Lipidology	2004	164
Niacin therapy in atherosclerosis Charles D. Meyers, Vajinath S Kamanna, Moti L. Kashyap Current Opinion in Internal Medicine ThrombosisVascular DiseaseNiacin TherapyCardiovascular DiseasePharmacology	2005	139
Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome Charles D. Meyers, Karine Tremblay, Ahmed Amer, Lipids in Health and Disease	2015	106
Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals Tania Garito, Ronenn Roubenoff, Marcus Hompesch, Diabetes Obesity and Metabolism	2017	81
The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes Yanling He, William G. Haynes, Charles D. Meyers, Diabetes Obesity and Metabolism	2019	80
Varying Cost and Free Nicotinic Acid Content in Over-the-Counter Niacin Preparations for Dyslipidemia Charles D. Meyers, Molly C. Carr, Sang Gyu Park, Annals of Internal Medicine	2003	72
Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: An in vitro model of the niacin flush Charles D. Meyers, Paul Liu, Vaijinath S. Kamanna, Atherosclerosis InflammationCytokineHuman MacrophagesMedicinePhysiology	2006	55
Pharmacokinetics, pharmacodynamics, safety, and tolerability of pradigastat, a novel diacylglycerol acyltransferase 1 inhibitor in overweight or obese, but otherwise healthy human subjects Charles D. Meyers, Ahmed M. Amer, Tapan Majumdar, The Journal of Clinical Pharmacology	2015	44
The DGAT1 Inhibitor LCQ908 Decreases Triglyceride Levels in Patients with the Familial Chylomicronemia Syndrome Charles D. Meyers, Daniel Gaudet, Karine Tremblay, Journal of clinical lipidology Metabolic SyndromeFamilial Chylomicronemia SyndromeLipid DisorderMetabolic DisorderMedicine	2012	32
Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDL Charles D. Meyers, Lisa R. Tannock, Thomas N. Wight, Journal of Lipid Research	2003	26

Page 1